Compare McKesson Corporation (MCK) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Remitly Global Inc — how do they compare? McKesson Corporation trades at $829.95 (market cap $97.35B), while Remitly Global Inc trades at $23.67 (market cap $5.02B). The key difference: McKesson Corporation is far larger — about 19.4× Remitly Global Inc's market cap, and McKesson Corporation pays a 0.39% dividend while Remitly Global Inc pays none. Which is the better fit depends on your goals.
| MCK | RELY | |
|---|---|---|
Market Cap | $97.35B | $5.02B |
Sector | Health | Technology |
52-Week High | $995.69 | $25.23 |
52-Week Low | $659.01 | $12.20 |
Enterprise Value | $101.98B | $4.41B |
Dividend Yield | 0.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
RELY trades at $23.84, down 1.2% on the day, with a bullish technical signal from moving averages and strong analyst consensus. The company shows accelerating revenue growth, reaching $1.64 billion in 2025, and achieved profitability with net income of $67.93 million. Recent news highlights expansion into the UAE market and positive earnings beats.
The outlook is positive, driven by market share gains in the remittance sector and raised 2026 guidance. Key risks include intense competition and execution challenges in international expansion. Wall Street sentiment is strongly bullish with a $27.40 price target, suggesting 15% upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
